SMS001 — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-11-18 in 3mo
ESTIMATED |
READOUT
An Adjuvant Study to Evaluate SMS001 (Paclitaxel) in Non-Small Cell Lung Cancer
Phase 2 · Carcinoma, Non-Small-Cell Lung Cancer (NSCLC) |
ToLymph Inc. | SMS001 |
ClinicalTrials.gov ↗
✓ Source-checked 2026-08-06
Sponsor-projected date — can change
|